Abiopharma

🔍 Silbermann Benjamin (Director)

Company: PINTEREST, INC. (PINS)

Report Date: 2026-06-23

Detailed Transactions and Holdings:

• Acquired 46,875 shares of Class A Common Stock (Direct)
  Date: 2026-06-23 | Code: C | equity_swap_involved: 0 | shares_owned_after: 46,875.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 26,534 shares of Class A Common Stock at $19.844 per share (Direct)
  Date: 2026-06-23 | Code: S | equity_swap_involved: 0 | shares_owned_after: 20,341.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Sold 20,341 shares of Class A Common Stock at $20.1757 per share (Direct)
  Date: 2026-06-23 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F4
• Acquired 46,875 shares of Class A Common Stock (Direct)
  Date: 2026-06-24 | Code: C | equity_swap_involved: 0 | shares_owned_after: 46,875.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 46,875 shares of Class A Common Stock at $19.8969 per share (Direct)
  Date: 2026-06-24 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F5
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-06-23 | Code: H | shares_owned_after: 13,996.00 | Footnotes: F6
• Sold 46,875 shares of Class B Common Stock (Derivative)
  Date: 2026-06-23 | Code: C | equity_swap_involved: 0 | shares_owned_after: 35,455,638.00 | transaction_form_type: 4 | Footnotes: F7, F1, F7, F7
• Sold 46,875 shares of Class B Common Stock (Derivative)
  Date: 2026-06-24 | Code: C | equity_swap_involved: 0 | shares_owned_after: 35,455,638.00 | transaction_form_type: 4 | Footnotes: F7, F1, F7, F7
• Holds 8,762,530 shares of Class B Common Stock (Derivative)
  Date: 2026-06-23 | Code: H | shares_owned_after: 8,762,530.00 | Footnotes: F7, F7, F7, F8
• Holds 1,174,715 shares of Class B Common Stock (Derivative)
  Date: 2026-06-23 | Code: H | shares_owned_after: 1,174,715.00 | Footnotes: F7, F7, F7

Footnotes:

• F1: Represents the conversion of shares of Class B Common Stock, par value $0.00001 ("Class B Common Stock") into Class A Common Stock, par value $0.00001 ("Class A Common Stock"), in connection with the sale of such shares pursuant to a Rule 10b5-1 trading plan.
• F2: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2026.
• F3: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.1400 to $19.9900 per share. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F4: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.0000 to $20.4350 per share. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F5: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.6400 to $20.2150 per share. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F6: Represents previously reported RSUs that are subject to vesting requirements.
• F7: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of the Class A Common Stock. Additionally, each share of Class B Common Stock will, subject to certain exceptions, convert automatically into one share of Class A Common Stock upon any transfer, and in other circumstances as outlined in the Issuer's Certificate of Incorporation.
• F8: Mr. Silbermann disclaims beneficial ownership of the shares held by the SFTC, LLC, a Delaware limited liability company owned by The Silbermann 2012 Irrevocable Trust. This report shall not be deemed an admission that he is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in such shares by virtue of certain of his immediate family members' interests in The Silbermann 2012 Irrevocable Trust.